93.00
+5.00
+(5.68%)
At close: 4:11:39 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 4 | 23 | 22 |
| Avg. Estimate | 19.28B | 19.73B | 79.41B | 84.83B |
| Low Estimate | 18.96B | 19.21B | 76.52B | 79.9B |
| High Estimate | 19.97B | 20.64B | 81.12B | 89.54B |
| Year Ago Sales | 19.16B | 18.9B | 75.93B | 79.41B |
| Sales Growth (year/est) | 0.61% | 4.39% | 4.58% | 6.82% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SIEB.F | -- | -- | -- | -- |
| S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
| Downgrade | Barclays: Equal-Weight to Underweight | 10/15/2021 |
| Downgrade | Goldman Sachs: Buy to Neutral | 9/18/2015 |
| Upgrade | HSBC: Hold to Buy | 8/28/2015 |
| Upgrade | Exane BNP Paribas: Reduce to Buy | 1/14/2015 |
| Downgrade | B of A Securities: Buy to Neutral | 1/12/2015 |